Given the fact that MS patients often demonstrated other platelet abnormalities such as thrombocytopenia [19], we decided to investigate possible actions of GA and IFN-β on their capacity to modulate platelet functions. The gene discussed is IFNB1; the disease is myeloid sarcoma.